Search by Drug Name or NDC

    NDC 62011-2520-01 Health Mart severe cold cough and flu 650; 25; 10 mg/1; mg/1; mg/1 Details

    Health Mart severe cold cough and flu 650; 25; 10 mg/1; mg/1; mg/1

    Health Mart severe cold cough and flu is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Strategic Sourcing Services LLC. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 62011-2520
    Product ID 62011-2520_77fbef72-9f87-40a4-9589-c415c0d31029
    Associated GPIs
    GCN Sequence Number 064453
    GCN Sequence Number Description diphenhyd/phenyleph/acetaminop POWD PACK 25-10-650 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 14359
    HICL Sequence Number 035433
    HICL Sequence Number Description DIPHENHYDRAMINE HCL/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Health Mart severe cold cough and flu
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 25; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Strategic Sourcing Services LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 62011-2520-01 (62011252001)

    NDC Package Code 62011-2520-1
    Billing NDC 62011252001
    Package 6 POWDER, FOR SOLUTION in 1 CARTON (62011-2520-1)
    Marketing Start Date 2015-10-09
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL da22996e-3e71-4309-a37b-01495e149272 Details

    Revised: 11/2020